PKC delta (PKCδ) promotes tumoral progression of human ductal pancreatic cancer

Pancreas

Volumn 39, Issue 1, 2010, Pages

  Mauro, Laura V ^a   Grossoni, Valeria C ^a   Urtreger, Alejandro J ^a   Yang, Chengfeng ^b   Colombo, Lucas L ^a   Morandi, Ana ^c   Pallotta, María G ^c   Kazanietz, Marcelo G ^d   Bal De Kier Joffé, Elisa D ^a   Puricelli, Lydia L ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ERK; Human pancreatic adenocarcinoma; Invasion; PI3K AKT; PKCC

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; DOXORUBICIN; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C DELTA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; CARCINOGENIC ACTIVITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PANCREAS DUCT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SIGNAL TRANSDUCTION; STARVATION; ANIMAL; CELL MOTION; CULTURE MEDIUM; DISEASE COURSE; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; ANIMALS; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PROTEIN KINASE C-DELTA; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 74049146296     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bce796     Document Type: Article

References (37)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
2. Ko AH. Future strategies for targeted therapies and tailored patient management in pancreatic cancer. Semin Oncol. 2007;34:354-364.
3. El-Rayes BF, Ali S, Philip PA, et al. Protein kinase C: a target for therapy in pancreatic cancer. Pancreas. 2008;36:346-352.
4. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer. 2007;7:281-294.
5. Parekh DB, Ziegler W, Parker PJ. Multiple pathways control protein kinase C phosphorylation. EMBO J. 2000;19:496-503.
6. Wang QJ, Bhattacharyya D, Garfield S, et al. Differential localization of protein kinase C delta by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J Biol Chem. 1999;274:37233-37239.
7. Steinberg SF. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem J. 2004;384:449-459.
8. Yang C, Kazanietz MG. Divergence and complexities in DAG signaling: looking beyond PKC. Trends Pharmacol Sci. 2003;24:602-608.
9. Tanaka Y, Gavrielides MV, Mitsuuchi Y, et al. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J Biol Chem. 2003;278:33753-33762.
10. Grossoni VC, Falbo KB, Kazanietz MG, et al. Protein kinase C delta enhances proliferation and survival of murine mammary cells. Mol Carcinog. 2007;46:381-390.
11. Liu JF, Crepin M, Liu JM, et al. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun. 2002;293:1174-1182.
12. Urtreger AJ, Grossoni VC, Falbo KB, et al. Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells. Mol Carcinog. 2005;42:29-39.
13. Grossoni VC, Falbo KB, Mauro LV, et al. Protein kinase C delta inhibits the production of proteolytic enzymes in murine mammary cells. Clin Exp Metastasis. 2007;24:513-520.
14. Basu A. Involvement of protein kinase C-delta in DNA damageYinduced apoptosis. J Cell Mol Med. 2003;7:341-350.
15. Alonso-Escolano D, Medina C, Cieslik K, et al. Protein kinase C delta mediates platelet-induced breast cancer cell invasion. J Pharmacol Exp Ther. 2006;318:373-380.
16. Alonso DF, Farias EF, Bal de Kier Joffe E. Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas. Cancer Lett. 1993;70:181-187.
17. Pittman RN. Release of plasminogen activator and a calcium-dependent metalloprotease from cultured sympathetic and sensory neurons. Dev Biol. 1985;110:91-101.
18. Reno EM, Haughian JM, Dimitrova IK, et al. Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors. Hum Pathol. 2008;39:21-29.
19. Kuranami M, Powell CT, Hug H, et al. Differential expression of protein kinase C isoforms in human colorectal cancers. J Surg Res. 1995;58:233-239.
20. Jackson DN, Foster DA. The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. FASEB J. 2004;18:627-636.
21. Liao L, Ramsay K, Jaken S. Protein kinase C isozymes in progressively transformed rat embryo fibroblasts. Cell Growth Differ. 1994;5:1185-1194.
22. Kiley SC, Clark KJ, Duddy SK, et al. Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene. 1999;18:6748-6757.
23. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
24. Zhong M, Lu Z, Foster DA. Downregulating PKC delta provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpression. Oncogene. 2002;21: 1071-1078.
25. Gonzalez-Guerrico AM, Kazanietz MG. Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: a key role for protein kinase C delta. J Biol Chem. 2005;280:38982-38991.
26. Nakagawa M, Oliva JL, Kothapalli D, et al. Phorbol esterYinduced G1 phase arrest selectively mediated by protein kinase CdeltaYdependent induction of p21. J Biol Chem. 2005;280:33926-33934.
27. McCracken MA, Miraglia LJ, McKay RA, et al. Protein kinase C delta is a prosurvival factor in human breast tumor cell lines. Mol Cancer Ther. 2003;2:273-281.
28. Clark AS, West KA, Blumberg PM, et al. Altered protein kinase C (PKC) isoforms in nonYsmall cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res. 2003;63:780-786.
29. Dziadziuszko R, Camidge DR, Hirsch FR. The insulin-like growth factor pathway in lung cancer. J Thorac Oncol. 2008;3: 815-818.
30. Jackson D, Zheng Y, Lyo D, et al. Suppression of cell migration by protein kinase Cdelta. Oncogene. 2005;24:3067-3072.
31. Noel A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol. 2008;19:52-60.
32. Juuti A, Lundin J, Nordling S, et al. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer. Oncology. 2006;71:61-68.
33. Zervos EE, Shafii AE, Haq M, et al. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro. J Surg Res. 1999;84:162-167.
34. Tanno S, Tanno S, Mitsuuchi Y, et al. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res. 2001;61:589-593.
35. Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res. 2006;66:3963-3966.
36. Yoeli-Lerner M, Toker A. Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle. 2006;5:603-605.
37. Diamantidis M, Tsapournas G, Kountouras J, et al. New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer. Curr Mol Med. 2008;8:12-37.